&w=3840&q=100)
HPV key factor for rise in cancer cases among Indian youth, say doctors
A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major contributing factor in the rise of cancers in young Indians, particularly among those in their twenties and thirties.
With increasing cases of cervical, oral, and oropharyngeal cancers linked to HPV infection, experts believe India is on the brink of a preventable cancer crisis if urgent measures are not implemented.
Dr Ashish Gupta, Chief of Medical Oncology at Amerix Cancer Hospital, New Delhi, said, "HPV-related cancers are striking far earlier than we used to see. Patients in their twenties are coming in with cervical, oral, and throat cancers -- many of which could have been avoided entirely with timely vaccination and proper awareness." "What's most heartbreaking is that HPV is preventable, yet many families and individuals are not even aware of the risk," Dr Gupta said.
Unlike other cancers that develop over decades, HPV-related cancers in young people often progress rapidly and silently.
Prevention through vaccination and early screening should be treated with the same urgency as any national health emergency.
"We need a focused, stigma-free, countrywide campaign that reaches schools, colleges, and parents," Gupta said.
The virus, which spreads primarily through intimate skin-to-skin contact, is known to be one of the most common sexually transmitted infections globally.
While the body clears most HPV infections on its own, certain high-risk strains can persist and lead to cancer.
In women, it is the leading cause of cervical cancer, while in men and women alike, it is now strongly linked to oral, anal, and throat cancers.
What troubles experts further is the lack of awareness and the social stigma that surrounds HPV discussions in India -- leading to poor vaccination rates and negligible screening coverage.
Dr Shubham Garg, Senior Oncologist at Dharamshila Narayana Superspeciality Hospital said, "HPV-related cancers don't give you many symptoms early on. That's why routine screening is so vital. A young woman with no symptoms may already have precancerous changes in the cervix. Similarly, oral HPV infections in men often go unnoticed until they present with full-blown tumors. Without education, vaccination, and routine checkups, we're allowing preventable cancers to spread unchecked."
Currently, India does not have a national HPV vaccination program for all adolescents, although the vaccines are approved and available in private settings.
Global studies have proven that vaccinating both boys and girls before they become sexually active significantly reduces HPV transmission and related cancers.
Experts believe that adopting universal HPV immunization for preteens, along with catch-up vaccinations for older teens and young adults, is the most effective strategy to curb this epidemic. However, vaccination alone isn't enough.
Dr Ashish Gupta further said that screening must become as commonplace and normalized as any other preventive health check.
"Our focus must be twofold -- educate and empower. The stigma surrounding HPV has kept us silent for too long. We must normalize conversations about the virus and its connection to cancer. Pap smears, HPV DNA tests, and oral screenings should be accessible in every district hospital and primary health center, he said.
Moreover, we need policies that include these services under national insurance schemes so that cost is never a barrier. We are not talking about an incurable disease. We are talking about a cancer that we can, in many cases, prevent before it even begins. That's a rare opportunity in oncology and one we must not waste," Dr Gupta added.
Dr Rahul Bhargava, Senior Oncologist at Fortis Memorial Research Institute, Gurugram concluded with a powerful reminder, "Every vaccinated child is one less cancer case in our future. Every screening that catches early-stage HPV impact is a life redirected toward health and hope. Let's not wait until it's too late. Prevention, in this case, is not just better than cure'?it's the only rational path forward.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
41 minutes ago
- Business Standard
Biological E to make HPV9 vaccine under licensing pact with Recbio
Hyderabad-based vaccine manufacturer Biological E (BE) on Monday announced it has entered a licensing agreement with Chinese pharma firm Jiangsu Recbio Technology Company to produce and commercialise Recbio's nine-valent Human Papillomavirus (HPV9) vaccine for India and global markets. The HPV9 vaccine, designed to protect against nine HPV types linked to cervical, vulvar, vaginal, anal and oropharyngeal cancers, as well as genital warts, is currently in Phase 3 clinical trials in China. As part of the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in UNICEF and PAHO tenders in other markets. Recbio will also provide BE with the drug substance (DS) and transfer the technology to formulate, fill, and package the vaccines. 'It will also include technology transfer for DS production at an appropriate time in the future,' Recbio said in a statement. In India, the estimated number of deaths due to cervical cancer stood at 35,691 in 2023, up from 34,806 in 2022 and 33,938 in 2021, according to a parliamentary response by the Union Health Ministry. Recbio claims that the nine-valent HPV vaccine is effective in preventing around 90 per cent of cervical cancers and 90 per cent of anal and genital warts. Commenting on the collaboration, Mahima Datla, Managing Director at BE, said the partnership aligns with the company's commitment to improve global health by making essential vaccines more accessible and affordable. The collaboration also marks a significant milestone for Recbio in entering the Indian and international markets, highlighting its potential in the innovative vaccine field. Liu Yong, Founder, Chairman and Chief Executive Officer (CEO) of Recbio, added that it will work together with BE to accelerate the launch process of the HPV9 vaccine in India. Following the signing of the technology licence agreement between the two companies, Recbio has begun transferring the necessary technical knowledge, materials, and expertise to BE to produce the HPV9 vaccine. BE is expected to begin large-scale manufacturing of the HPV9 vaccine once the technology transfer is completed. Currently, BE supplies its vaccines to more than 140 countries, and its therapeutic products are sold in India, the US and Europe. It had recently received approval for India's first 14-valent Pneumococcal Conjugate Vaccine.


India Today
an hour ago
- India Today
The common disorder hiding behind loud snores
The common disorder hiding behind loud snores Credit: Generative AI/India Today Snoring loudly every night is not just disturbing for a partner but an underlying disorder known as obstructive sleep apnea. Credit: Getty Images Sadly, over 104 million Indians have the same problem, more prevalent in men than in women. According to Dr. Sarmishtha Bandyopadhyay, a senior ear, nose and throat specialist at Neotia Mediplus OPD and Diagnostics Clinic, obstructive sleep apnea is considered one of the single most important causes of coronary artery disease in recent times. Obstructive Sleep Apnea (OSA) is a condition where a person stops breathing for short periods while sleeping because their airway gets blocked. What is obstructive sleep apnea? When you sleep, the muscles in your throat relax. But in some people, these relaxed muscles collapse too much or the tongue falls back, blocking the airflow. This makes the person stop breathing for a few seconds, sometimes many times, during the night. The brain notices the lack of oxygen and briefly wakes the person up to breathe again, often without them realising it. As a result, people with OSA snore loudly (a common sign), feel very tired during the day, may wake up gasping or choking at night, and may have headaches or trouble concentrating. OSA is linked to high blood pressure, heart disease and stroke, type 2 diabetes, weight gain, and metabolic issues. It also causes cognitive decline and memory problems. "Obstructive sleep apnea puts your heart under stress because your oxygen levels keep dipping throughout the night. Over time, this leads to long-term cardiovascular strain," Dr. Bandyopadhyay told A sleep test (polysomnography) helps diagnose the condition, following which most doctors recommend using a CPAP (continuous positive airway pressure) machine. Treatment


Time of India
2 hours ago
- Time of India
Connectivity, Standardisation, and Inclusion Are the Pillars of a Health-First India
New Delhi : In an exclusive conversation, Dr. Pemmasani Chandrasekhar , Minister of State for Communications and Rural Development , spoke to Prathiba Raju , Senior Assistant Editor, ETHealthworld and shared how digital infrastructure—powered by 4G, 5G, BharatNet, and the upcoming 6G vision—is shaping India's healthcare future. A healthcare professional himself, Dr. Pemmasani outlines why "connectivity, standardization, and inclusion are the pillars of a Health-First India." Q. Dr. Pemmasani, as both a healthcare professional and policy leader, how do you see telecom serving as a true catalyst for building a Health-First India through uninterrupted digital connectivity? Telecom is fundamentally about connectivity, and connectivity is the foundation of modern healthcare. Healthcare is becoming increasingly digital—from physicians accessing real-time clinical data and patient histories to improving coordination, reducing duplication, and minimizing errors. All of this depends on robust, uninterrupted digital infrastructure. Inclusivity is equally important. For rural or remote patients, even basic access to care can be a challenge. Whether it's teleconsultations or even remote surgeries, high-quality connections—via 5G or fibre optics—are essential. With 65–70% of our population still in rural areas, bridging the digital divide is not optional—it's critical. Q. The government has made significant progress through initiatives like BharatNet, 4G and 5G rollout. How do you see these efforts translating into equitable healthcare access in rural and remote areas, and what are the next priorities for truly bridging this urban-rural digital health divide? Today, over 95 per cent of India has 4G coverage, and we're actively working to upgrade the remaining villages. Over 25 crore Indians now have 5G-ready devices. Through BharatNet, we've already connected over 2.15 lakh gram panchayats with optical fibre, and another 40,000 are underway. To ensure long-term reliability, we've introduced 10-year maintenance contracts and shifted from linear to ring-based network structures—so if one path is disrupted, another route ensures continuity. These measures will drastically reduce service disruptions and increase trust in the system, especially for healthcare delivery. Q. How will Bharat 6G help revolutionise healthcare as India transforms from a technology adopter to a global standard-setter? Additionally, how is Bharat's 6G Vision attracting global partnerships and driving breakthroughs in terahertz communication and AI-native networks? 6G will deliver speeds 10–15 times faster than today, with near-zero latency, approaching optical fibre-level reliability. That opens immense possibilities—from real-time diagnostics to robotic surgeries and seamless remote care. Importantly, unlike with 4G and 5G, where we were adopters, India is now shaping global 6G standards. The government has funded over 100 R&D projects—many in partnership with IITs—to develop intellectual property and play a leading role in global tech development. Q. Platforms like eSanjeevani, ABDM, and Tele-MANAS are transforming public health delivery. How is telecom infrastructure being aligned to support these initiatives at scale—ensuring seamless, interoperable healthcare for every citizen? Reliable connectivity ensures that people can access care from their homes—follow-up visits, nursing support, mental health services, and more—without long wait times at hospitals. It builds trust. Once citizens trust the system, they're more likely to use it. We're aligning our telecom expansion to support platforms like eSanjeevani and ABDM, so that healthcare is not just digitally available but also consistent and user-friendly across all levels—from rural health centres to AIIMS. Q. Given that the Department of Telecommunications (DoT) is not currently undertaking consultations with civil society, experts, or researchers on framing rules for internet suspension under the Telecommunications Act, 2023, how will the Ministry ensure that internet shutdowns do not hinder access to essential healthcare services, particularly in underserved areas? Internet shutdowns are extremely rare and treated as exceptions. They're only imposed when the government believes the risk to public order outweighs the benefit. Such decisions undergo strict review processes every 24 hours and cannot exceed 15 days under any circumstance. Importantly, any shutdown requires authorisation from both state and central secretaries, ensuring that no unilateral action disrupts essential services like healthcare. Q. With the convergence of 5G, AI, IoT, and cloud, what opportunities do you see for technology to address India's healthcare challenges—particularly in diagnostics, treatment, mental health, and workforce shortages? Integration is the key. We need a system where electronic health records, insurance, pharmacies, and preventive care are all connected. This will allow us to make data-driven decisions, ensure pricing transparency, avoid drug errors, and forecast disease burdens more accurately. Emerging tech—especially AI and cloud computing—can fill critical gaps in mental health access, diagnostics, and workforce shortages by enabling remote triage, virtual counselling, and decision support tools for clinicians. Q. What is your vision for a digitally empowered healthcare system where every doctor—whether in an AIIMS, a private clinic, or a rural PHC—can deliver world-class care? And how can industry, the medical community, and citizens contribute to this journey? It all starts with standardisation and capacity building. We must ensure that doctors, nurses, and paramedics meet well-defined competencies before entering the healthcare system. We need to raise the bar for medical education and test whether these professionals are truly prepared. At the infrastructure level, every hospital—public or private—must follow accreditation norms. The private sector, tech industry, and citizens can contribute by investing in healthtech, promoting responsible data use, and adopting digital tools that improve care outcomes. Ultimately, connectivity, standardization, and inclusion will drive us toward a truly Health-First India. Watch the conversation here: